 |
CTTG’s attorneys have extensive experience in technology
transfer. As technology transfer professionals at the National Institutes
of Health, they assisted government scientists and researchers to establish
partnerships with industry for the development of a wide range of technology.
In private practice they have represented pharmaceutical companies, medical
device and dietary supplement manufacturers, law firms, and academic medical
centers on technology transfer matters and regulatory issues concerning
the clinical research and development of drugs, medical devices, natural
products, and dietary supplements.
Kate Duffy Mazan is an attorney in private practice in McLean, VA. She is the founding member of The Clinical Technology Transfer Group (CTTG). CTTG is a law firm concentrating in technology transfer and regulatory compliance in the clinical setting.
For the past 15 years Kate has practiced exclusively in the area of food and drug law with an emphasis on the regulation of clinical research. In private practice she has assisted a variety of companies and institutions in complying with federal and state laws and regulations governing the conduct of clinical trials. Kate has extensive experience in the negotiation of clinical trial agreements and the regulatory review of clinical research practices. Prior to entering private practice, Kate worked for nine years at the National Cancer Institute (NCI) within the National Institutes of Health. As a technology transfer professional at NIH she managed the intellectual property portfolio of NCI’s Natural Products Branch, negotiating CRADAs and international agreements with countries in Africa, Central and South America, and the Pacific rim. Kate also worked with scientists from several other institutes within NIH to develop a wide range of technology. She began her career at NIH as Chief of NCI’s Cancer Information Service (CIS), a nationwide network of cancer information and education programs located at major cancer centers across the country. In that capacity she was responsible for developing a training program on the conduct of clinical trials to assist information specialists explain clinical research to patients and the public.
Kate holds a law degree from the Columbus School of Law at the Catholic University of America, Washington, D.C., a Master of Science in Public Health Administration from the University of Massachusetts Amherst, and an A.B. from Stonehill College, North Easton, Massachusetts. Kate is admitted to practice law in Virginia, Maryland, and the District of Columbia.
Kathleen Sybert has over twenty years of experience in the
life sciences, including as a researcher and inventor in the biotechnology
industry,
and as a technology transfer professional at the National Cancer Institute
(NCI) of the National Institutes of Health (NIH).
At NCI, Kathleen served
as Chief of the Technology Transfer Branch, supervising a staff of professionals
with backgrounds in law, science,
medicine and
business management, who served the technology transfer needs of M.D.
and Ph.D. scientists at twelve of NIH’s Institutes and Centers.
Kathleen advised pharmaceutical and other commercial organizations as
well as universities and other non-profit institutions about the compatibility
of their proposed projects with the research and development goals of
NCI, especially those of the Developmental Therapeutics and Cancer Therapy
Evaluation Programs of the Division of Cancer Treatment and Diagnosis.
Kathleen also advised commercial and non-profit recipients of federal
funding about the government’s rights and interests in inventions
made under grants and contracts, including Small Business Innovation
Research awards (SBIRs), and cooperative agreements. She worked closely
with industrial,
academic and federal scientists, attorneys and business managers in
drafting and negotiating Cooperative Research and Development Agreements
(CRADAs),
clinical trial agreements, material transfer agreements and confidential
disclosure agreements. Kathleen also participated in revising model
agreements for NCI and NIH, including license agreements. While at NCI,
Kathleen
team taught the technology transfer course at the Foundation for Advanced
Education in the Sciences graduate school at NIH, and served a term
as Chair of the NIH Technology Development Coordinators, which included
sitting
with the Public Health Service Technology Transfer Policy Board.
Before
joining NCI, Kathleen was a research scientist at three Maryland biotechnology
corporations, including the Viral Science Laboratory of
Electronucleonics Laboratories, where she helped established their first
Institutional Biosafety Committee; Igene Biotechnology, where she participated
in the company’s start-up phase; and Advanced Biotechnologies, where
she worked in a Biosafety–Level 3 laboratory environment.
Kathleen
is co-author of an Association of University Technology Managers (AUTM)
Technology Transfer Practice Manual chapter on CRADAs, and a Practicing
Law Institute Biotechnology Patents and Business Strategies program
paper entitled Government Funding and Research and Development Collaborations
with Biotechnology Companies.
Kathleen holds a law degree from the Washington
College of Law at American University, Washington, D.C., and a Ph.D.
in Biology from the University
of Maryland. She is admitted to practice law in Maryland, Pennsylvania, and before
the United States Patent and Trademark Office.
 Of Counsel
 nsiegel@cttg-law.com
Nancy brings a uniquely diverse background in regulatory practice in regulated industry. For over ten years Nancy was a legislative and regulatory counsel for the American Insurance Association. She had responsibility for a diverse portfolio of regulatory practice areas, including rate making, regulatory compliance, automobile insurance, anti-trust, surplus lines and surety. Nancy regularly advised representatives of large nationwide property/casualty insurance companies, lobbyists, and regulators on a full array of regulatory issues in these areas. She had responsibility for testifying before state legislatures and regulatory agencies on legislative and regulatory initiatives affecting member companies, and developed and communicated policy positions to industry lobbyists and regulators. She coordinated policy with industry organizations, specialty boards, trade associations, and major insurance companies. Nancy also published a comprehensive 50-state survey and analysis of property/casualty insurance rate laws as well as a similar guide for workplace drug testing laws.
 Associate
jwilliford@cttg-law.com
John joined CTTG full time as an Associate in October 2010 after serving as a Summer Associate and paralegal since May 2009. John handles a wide range of contractual negotiations, specifically Clinical Trial Agreements and Non-Disclosure Agreements.
Prior to joining CTTG, John worked as a law clerk for Mark Barnes and Associates engaging in corporate regulatory compliance for firearms manufacturers and defense contractors focusing in international trade policy and import/export controls.
John earned his law degree, cum laude from the Washington College of Law at American University, Washington, DC. During law school, John served as a Student Attorney for the General Practice Clinic where he represented pro bono clients in bankruptcy, probate, and home foreclosure matters. John received his B.A. in International Affairs and Political Science from the Elliott School of International Affairs at the George Washington University where he served as Vice President of Judicial and Legislative Affairs for the University’s Student Government and interned for Senator Edward M. Kennedy.
|
 |
 |
Kate
Duffy Mazan, Esq.
Kathleen Sybert, Ph.D., Esq.
